Neuropsychiatric Disease and Treatment

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Artificial Intelligence and Machine Learning in Neuropsychiatric Disease Diagnosis, Prognosis, and Treatment" in Neuropsychiatric Disease and Treatment.

Artificial intelligence (AI), machine learning (ML), and data mining (DM) have become pivotal tools in revolutionizing the diagnosis, treatment, and management of neuropsychiatric diseases. These technologies, capable of handling vast amounts of complex data, offer innovative solutions to traditional clinical approaches. The intersection of AI, ML, and neuropsychiatry is expanding rapidly, bringing about groundbreaking advancements in understanding conditions such as Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Anxiety and Depressive Disorders, Schizophrenia, and other cognitive disorders. By leveraging data-driven techniques, it is now possible to detect patterns in patient data that were previously difficult to identify, enabling early detection, personalized treatment, and improved patient outcomes. This Article Collection will explore how AI, ML, and DM are being applied to neuropsychiatric diseases, highlighting recent research and methodologies.

The importance of this topic lies in its potential to address some of the most pressing challenges in neuropsychiatric healthcare. Traditional diagnostic methods, based on clinical judgment and limited patient data, often fail to capture the complexity of brain disorders. The integration of AI and ML techniques, such as neural networks, deep learning, and reinforcement learning, promises to enhance diagnostic accuracy, predict disease progression, and optimize treatment strategies. Additionally, the ability of AI and ML to analyze multimodal data, including genetic, neuroimaging, and behavioral data, could lead to the discovery of novel biomarkers and personalized therapeutic interventions. As these technologies become more refined, they hold the potential to revolutionize how neuropsychiatric conditions are understood and treated.

This Article Collection will focus on the cutting-edge applications of AI, ML, and DM in the field of neuropsychiatry. We welcome original research, survey papers, meta-analyses, and review articles that explore the following subtopics including but not limited to:

• AI/ML in Neuropsychiatric Disease Diagnosis and Prognosis: Studies on how AI models, including deep learning and reinforcement learning, can be used to predict disease onset, progression, and therapeutic response.
• AI/ML Models for Biomarker Discovery: Utilizing machine learning algorithms to identify novel biomarkers for neuropsychiatric conditions, focusing on genetic, neuroimaging, and clinical data integration.
• Personalized Treatment through AI/ML: Exploration of AI-driven approaches in tailoring treatments for patients based on their unique genetic, clinical, and environmental factors.
• Data Mining Techniques in Cognitive Disorder Management: Application of advanced data mining algorithms to clinical datasets for the early detection and monitoring of conditions like schizophrenia, bipolar disorder, and depression.
• Neuroimaging and Neuroinformatics in AI/ML: Development of AI/ML algorithms to analyze neuroimaging data (e.g., MRI, PET scans) for better understanding of brain structures associated with neuropsychiatric disorders.
• Challenges and Ethical Considerations in AI/ML in Neuropsychiatry: Addressing issues related to data privacy, ethical implications, and bias in AI/ML models when applied to sensitive health data.

This Article Collection will appeal to researchers, clinicians, and technologists interested in how AI and ML can improve the diagnosis, treatment, and management of neuropsychiatric diseases.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 June 2026.

Please submit your manuscript on our website, quoting the promo code HXCWA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr Sathishkumar V Easwaramoorthy, Sunway University

[email protected]

Professor Vetriselvan Subramaniyan, Sunway University

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Environmental Factors in Neuropsychiatric Pathophysiology and the Role of Alternative Therapeutic Approaches" in Neuropsychiatric Disease and Treatment.

Neuropsychiatric disorders, including depression, anxiety, schizophrenia, and bipolar disorder, arise from a complex interplay of genetic, neurobiological, and environmental factors. Among these, environmental influences play a pivotal role in shaping brain function and mental health. Exposure to psychological stress, trauma, sleep dysfunction, toxicants, infections, and socioeconomic factors can contribute to neuropsychiatric pathophysiology by altering neurochemical balance, inflammatory pathways, and neuronal signaling and plasticity. While conventional treatments such as pharmacotherapy and psychotherapy remain the cornerstone of management, alternative therapeutic approaches are gaining recognition for their potential to complement traditional treatments. New concepts in nutritional psychiatry, gut microbiome, mindfulness-based therapies, transcranial magnetic stimulation, exercise, and herbal medicine have led to propositions and explorations of alternative interventions for treating mental health disorders based upon their neuroprotective and neuromodulatory effects. This Article Collection aims to explore the intricate relationship between environmental factors and neuropsychiatric disorders, while also evaluating the efficacy and mechanisms of alternative therapeutic approaches for holistic, personalized treatment.

With increased life expectancies coupled with detrimental life-style changes, there has been a tremendous rise in the global burden of neuropsychiatric disorders. They have become a leading cause of disability worldwide, affecting millions of individuals. Environmental influences (e.g., chronic stress, pollution, urbanization, socioeconomic disparities, trauma, sleep issues, poor nutrition, etc.) play a crucial role in both the development and progression of these multifactorial and heterogeneous of neurological conditions. While pharmacotherapy and psychotherapy remain standard treatments, they are not always effective for all patients and may have side effects. Novel alternative treatments are being proposed regularly and are gaining scientific validation for a more comprehensive, patient-centered approach to neuropsychiatric care. Thus, identification of modifiable environmental risk factors and exploring alternative therapies can lead to prevention and early intervention, and more effective, personalized, and holistic treatment strategies.

This Article Collection will explore the complex interaction between environmental exposures and neuropsychiatric pathophysiology while evaluating the potential of alternative treatment approaches. The subtopics include, but are not limited to, (i) environmental factors contributing to neuropsychiatric disorders: chronic stress, trauma, and early-life adversity, influence of pollutants, heavy metals, and endocrine disruptors, urbanization, socioeconomic status, and lifestyle factors, (ii) neurobiological mechanisms linking environmental stressors to psychiatric disorders: neuroendocrine changes, alterations in neurotransmitter (dopamine, serotonin, glutamate) systems and neuroplasticity, oxidative stress, neuroinflammation and gut microbial dyshomeostasis, and (iii) alternative therapeutic approaches for neuropsychiatric disorders: nutritional psychiatry (ketogenic diet, micronutrients, and omega-3 fatty acids, etc.), mindfulness-based interventions and meditation, mental and physical activity, gut microbiome modulation, non-invasive brain simulation (TMS, tDCS, etc.), herbal medicines. Both reviews and original research will be entertained.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 April 2026.

Please submit your manuscript on our website, quoting the promo code NRCCP for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr. Faraz Ahmad, Vellore Institute of Technology, India

[email protected]

Dr. Faraz Ahmad’s research focusses on understanding the molecular mechanisms of synaptic pathology in a range of neuronal disorders, ranging from early-life stress to ageing-induced cognitive decline. He’s also interested in devising and evaluating phytotherapy-based strategies for neuroprotection.

Dr. Shafiul Haque, Jazan University, Saudi Arabia

[email protected]

Dr. Shafiul Haque has been offering 15+ years of accomplished experience in health sciences/ biomedical sciences /life sciences research, academia, bio-business with flare of research strategy and scientific management, team leadership, design & development of biological research projects/products, research application support and R&D project management.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Addiction in the Digital Age: Emerging Challenges in Neuropsychiatry" in Neuropsychiatric Disease and Treatment.

Behavioral addictions encompass a range of compulsive behaviors that, similar to substance use disorders, are characterized by neurobiological and psychological mechanisms. Despite the many positive effects of the rise of digitalization, problematic internet use, smartphone, video game, and social media addictions have been observed to increase steadily. In addition, gambling, exercise, shopping, eating, pornography, and sexual behavior addictions represent other significant types of behavioral addictions. The World Health Organization has emphasized that such addictions may affect a substantial proportion of the global population. Although each type of behavioral addiction exhibits unique features, they share common core characteristics, including emotional dysregulation, impulsivity, compulsivity, and disruptions in biological, psychological, social, and spiritual functioning. Addictions emerge from individuals’ pathological pursuit of reward and/or relief. Rewarding stimuli exert their effects through positive reinforcement mechanisms, while genetic variations related to the dopaminergic system, GABA, and other neurotransmitters shape behavioral outcomes. Understanding this multifaceted phenomenon requires an interdisciplinary approach encompassing neuroscience, psychology, and social sciences. Examining the prevalence of behavioral addictions, their associated components, and the underlying neuropsychiatric mechanisms through international research is expected to contribute significantly to a better understanding and prevention of addictions.

Global research reveals a significant increase in the prevalence of behavioral addictions. Technological advancements in the digital age put young people, the future of our world, at risk for various behavioral addictions, particularly technology addictions. These addictions, due to their increasing prevalence and their negative impact on individuals and society, are becoming a serious public health problem. In addition to exhibiting similar mechanisms of action to substance use disorders, such as dysregulated reward processing and impulsivity, they also increase mental health problems and lead to significant reductions in overall well-being and quality of life. The fact that they particularly affect younger generations and the ever-increasing rate of addiction highlights the urgent need for clinicians to address this issue. Therefore, addressing the prevalence of behavioral addictions, their associated factors, the neuropsychiatric mechanisms that contribute to them, and effective prevention and intervention are crucial to reducing their individual and societal burden and promoting healthier behavioral patterns.

With the rapid rise of digitalization, problematic internet use, smartphone, and social media addictions have steadily increased. Additionally, gambling, excessive exercise, shopping, eating, sexual behavior addictions represent other significant forms of behavioral addiction that may affect a substantial proportion of the global population, as highlighted by the World Health Organization. Despite their diversity, these conditions share core features such as emotional dysregulation, impulsivity, compulsivity, and impairments in biological, psychological, social, and spiritual functioning. Behavioral addictions stem from the pathological pursuit of reward and/or relief, often linked to dopaminergic pathways, GABAergic activity, and genetic variations influencing neurotransmission. Understanding this multifaceted phenomenon requires an interdisciplinary approach involving neuroscience, psychiatry, psychology, and social sciences. This Article Collection welcomes original research, systematic reviews, expert opinions, and extended reports that investigate the prevalence, underlying mechanisms, and related components of behavioral addictions through an international lens.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 980B8 to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31 August 2026.

Please contact Sam Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisors

Zeynep Öztürk, Erzurum Technical University

[email protected]

Dr. Zeynep Öztürk is an Assistant Professor of Psychiatric Nursing at Erzurum Technical University's Faculty of Health Sciences. She focuses on psychiatric nursing, mental health, addictions, resilience, spirituality in health, and elder care. She has published extensively in leading international journals in her field. She has authored over 20 publications indexed in Scopus and Web of Science. Dr. Öztürk also serves as a reviewer for several international journals and has led multiple clinical research projects.

Abdelaziz Hendy, Ain Shams University

[email protected]

Dr. Abdelaziz Said Hendy is an Assistant Professor of Pediatric Nursing at Ain Shams University, Egypt, and Assistant Professor at the College of Nursing, Qassim University, Saudi Arabia. He specializes in neonatal and pediatric nursing, nursing education, and public health. He serves as Academic Editor at PLOS ONE, Associate Editor at SAGE Open Nursing, and Editorial Board Member at BMC Nursing. With more than 50 publications indexed in Scopus and Web of Science, including contributions to The Lancet, his research focuses on advancing evidence-based neonatal and pediatric care. He is also an active reviewer for leading international journals and a member of the Scientific Council for the Neonatal Nursing Fellowship.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Cognitive Enhancement in Psychiatric Disorders" in Neuropsychiatric Disease and Treatment.

Cognitive impairment (CI) is prevalent in patients with various psychiatric conditions, e.g., schizophrenia, mood disorders, developmental disorders, and substance abuse. As CI is a major determinant of functional outcome, many years have been devoted to identifying treatment methods, including pharmacotherapy, rehabilitation and neuromodulation, that would effectively alleviate CI. While the evidence for the benefits of cognitive rehabilitation (remediation) therapy is relatively abundant, limited information has been available on cognition enhancing drugs (i.e., cognitive enhancers) that produce substantial effects on CI in psychiatric disorders.

Further efforts are needed to increase the chance of success of clinical trials evaluating cognitive enhancers, non-invasive brain stimulation methods, psycho-social intervention (cognitive rehabilitation/remediation). Importantly, such efforts should include the development of novel compounds or neuromodulation methods that show a greater ability to enhance cognitive function. Considerations should also be directed to the refinement of the study design, e.g., rational patient stratification and optimization of outcome measures. To effectively attain these goals, cutting-edge knowledge of the neurobiology of CI associated with psychiatric illnesses is required.

Prospective papers will deal with genetic, molecular, imaging, physiological, psychological, and/or behavioral issues regarding the mechanisms, assessment, and treatment of CI in psychiatric illnesses. Types of articles include Original Research, Reviews, Study Protocols, and Letter to the Editor. Also, Expert Opinion and Perspectives may be requested by Guest Advisor with an invitation basis. Overall, this Topic will provide the up-to-date knowledge on the mechanisms of CI associated with psychiatric illnesses and its treatment strategies, which will help facilitate social inclusion of patients and caregivers.

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 3A5AF to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31 August 2026.

Please contact Sam Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Antipsychotic Treatments - Transforming Schizophrenia Management in the Modern Era" in Neuropsychiatric Disease and Treatment.

We are pleased to announce a new Article Collection in Neuropsychiatric Disease and Treatment, dedicated to the game-changing role of antipsychotic treatments in the management of schizophrenia.

Since their clinical introduction, antipsychotic treatments have revolutionized care for patients with schizophrenia, offering benefits in reducing psychotic symptoms, stabilizing mood and emotions, improving cognitive and occupational functioning, and suicide prevention.

Given their global importance, Neuropsychiatric Disease and Treatment invites submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of antipsychotics in the management of schizophrenia.

The Collection, edited by the Editor-In-Chief Dr. Roger Pinder, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of antipsychotic treatment in schizophrenia, the Editors are particularly interested in manuscripts relating to the following areas, including but not limited to:

• Novel antipsychotic drug mechanisms, pharmacology, and targets
• Clinical effectiveness of antipsychotic drugs on reduction of psychotic symptoms and emotional regulation
• Impact of antipsychotic treatments on cognition, functional recovery, and neurobiological changes
• Efficacy and safety of antipsychotics for optimizing treatment and minimizing side effects
• Long-acting injectable (LAI) antipsychotic drugs for improving treatment adherence and patient outcomes
• Innovations and technologies in personalized antipsychotic treatment

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission TQYVE. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Neuromodulation in Neuropsychiatric Disorders" in Neuropsychiatric Disease and Treatment.

We are pleased to announce a new Article Collection in Neuropsychiatric Disease and Treatment, dedicated to the game-changing role of neuromodulation therapies in the management of neuropsychiatric disorders.

The collection, edited by the Editor-In-Chief Dr. Roger Pinder, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of neuromodulation in neuropsychiatric disorders, the Editors are particularly interested in those that are being used within the clinic:

• Transcranial magnetic stimulation (TMS) for depression and obsessive-compulsive disorder (OCD)
• Electroconvulsive therapy (ECT) for depression and other mood disorders
• Vagus nerve stimulation (VNS) for depression and epilepsy
• Deep brain stimulation (DBS) for Parkinson’s disease and OCD
• Cranial electrotherapy stimulation (CES) for depression, anxiety, and insomnia

Submissions on other neuromodulation therapies in treating neuropsychiatric disorders are also welcome. The subtopics of interest include but are not limited to:

• Neurological mechanisms and pathways
• Clinical benefits and long-term outcomes
• Cognitive and emotional effects
• Risks, side effects, and safety considerations
• Technical innovations and personalized approaches

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission NZIEY. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 1 April 2026.

View all papers in this article collection